methylprednisolone has been researched along with Leukemia, Myelomonocytic, Chronic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hikota-Saga, R; Horiuchi, T; Kato, S; Kimura, F; Kobayashi, A; Kobayashi, S; Maekawa, T; Osawa, Y; Sato, K; Watanabe, J; Yamamura, T | 1 |
| Babel, J; Bašić Kinda, S; Gveric-Krecak, V; Krecak, I; Medic, MG; Radonic, R; Roncevic, P | 1 |
| Cai, Y; Lin, Z; Liu, H; Teng, R; Zhang, Y | 1 |
| Czarnetzki, BM; Krüger-Krasagakes, S; Lippert, U; Möller, A; Nürnberg, W; Welker, P | 1 |
| Imanaka, F; Takimoto, Y | 1 |
| Cetin, M; Gümrük, F; Hiçsönmez, G; Tunç, B; Tuncer, AM; Yenicesu, I | 1 |
| Aktaş, D; Cetin, M; Hiçsönmez, G; Koç, A; Olcay, L; Tunçbilek, E; Tuncer, M; Yenicesu, I | 1 |
7 other study(ies) available for methylprednisolone and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
Topics: Cytokines; Forecasting; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation Mediators; Leukemia, Myelomonocytic, Chronic; Loss of Function Mutation; Methylprednisolone; Phosphorylation; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-cbl; Pyrin; Signal Transduction; STAT5 Transcription Factor; Tumor Cells, Cultured | 2018 |
Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab.
Topics: ADAMTS13 Protein; Autoantibodies; Coombs Test; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukemia, Myelomonocytic, Chronic; Methylprednisolone; Middle Aged; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Rituximab | 2020 |
Chronic myelomonocytic leukemia presenting as relapsing thrombotic thrombocytopenic purpura.
Topics: Aged; Fatal Outcome; Female; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Chronic; Methylprednisolone; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence | 2013 |
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.
Topics: Administration, Topical; Anti-Inflammatory Agents; Cytokines; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Leukocytes, Mononuclear; Lipopolysaccharides; Methylprednisolone; Tumor Cells, Cultured | 1996 |
[Chronic myelomonocytic leukemia with repeated respiratory failure associated with leukocytosis following splenic arterial embolization and splenectomy].
Topics: Adult; Embolization, Therapeutic; Female; Humans; Leukapheresis; Leukemia, Myelomonocytic, Chronic; Leukocytosis; Methylprednisolone; Respiratory Insufficiency; Splenectomy; Splenic Artery | 1996 |
Dramatic resolution of pleural effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone.
Topics: Adolescent; Apoptosis; Child; Dyspnea; Fatal Outcome; Female; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Chronic; Male; Methylprednisolone; Neoplastic Stem Cells; Pleural Effusion, Malignant | 1998 |
Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Methylprednisolone; Myelodysplastic Syndromes; Prospective Studies; Remission Induction; Sarcoma, Myeloid; Treatment Outcome | 2001 |